Skip to Main Content

Paper Details

Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
12
2021
Author NameAffiliation
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
George D YancopoulosRegeneron Pharmaceuticals, Inc.
  • 1 - 2

Datasets

Release 1.2